Multiple Sclerosis

Fingolimod approved!

First, the good news, a week ago the EMEA informed positively for Gilenya (Fingolimod) approval. This will expand the spectrum of therapeutic options for patients with multiple sclerosis and will fulfill the long desired availability of oral drugs for that chronic disease. The bad news are that only selected patients will have access to this […]

Disimmune neuropathies Inflammatory myopathies Multiple Sclerosis Myasthenia Gravis Others Paraneoplastic disorders

Plasmapheresis guidelines for NeuroImmune disorders

AAN evidence based reviews don’t add anything new to what we probably know (or should know) or suspect about a treatment or intervention, but it’s always useful to have all data summarized to avoid the whole process of revision by oneself. In the last issue of Neurology journal we’ll find an evidence-based review about the […]